In the pediatric patient population, studies found t(8; 21) was associated with MS [11], and higher levels of RUNX1/RUNX1T1 transcripts are risk factors for poor relapse-free survival (RFS) in MS patients [12]. Here, RUNX1 is linked to myeloid sarcoma.